Palpation of the mammary gland: examination and self-examination techniques

Breast palpation is a basic element of an in-person examination for complaints of a lump, pain, nipple discharge, skin changes, or breast shape. It is not a standalone screening method, but rather part of a clinical examination that helps select the appropriate imaging and invasive verification strategy. In the presence of complaints or a "palpable mass," palpation is included in the "triple assessment": history and examination, imaging, and morphological verification. [1]

Current guidelines emphasize that for women at average risk, clinical breast examination and self-examination have not been shown to improve survival over regular screening. Mammography is recognized as routine screening, while the role of clinical examination is diagnostic for symptoms and part of the physical examination at the office. [2]

The United States Preventive Services Task Force's updated position on April 30, 2024, recommends starting screening mammography every 2 years at age 40, with the caveat that there is "insufficient evidence" for additional ultrasound or magnetic resonance imaging for dense tissue and for women over 74 years of age. This is important for understanding the location of palpation: it does not replace screening or compensate for the limitations of imaging. [3]

The American Cancer Society confirms that clinical examination and regular self-examination as screening for average-risk individuals are not recommended; instead, "awareness"—knowing your normal range and promptly addressing changes—is encouraged. However, if you have increased risk or specific symptoms, your doctor may perform a clinical examination as part of your evaluation. [4]

When palpation is especially necessary: indications and red flags

Indications for targeted palpation and advanced diagnostics include a new palpable mass, progressive asymmetry, nipple retraction, "lemon peel" appearance, localized skin thickening, bloody or unilateral spontaneous discharge. Palpable axillary lymphadenopathy is a separate finding. These signs require a systematic examination of both breasts and lymphatic drainage areas. [5]

The UK Cancer Referral System (NICE NG12) classifies the following as urgent indications: in women aged 30 years or older – an unexplained breast lump; in women aged 50 years or older – nipple or skin changes (including eczematous changes) or unilateral persistent discharge; any palpable lesion that persists beyond the menstrual cycle. These criteria help translate palpation findings into clear routes. [6]

In men, a firm, painful disc-shaped nodule under the areola is more often consistent with gynecomastia, but a unilateral firm nodule, especially with skin changes or nipple discharge, requires the same oncologic alertness and imaging-morphological examination. [7]

During pregnancy and lactation, palpation is mandatory for any new mass, redness, tenderness, or "narrow segment" of engorgement. Differential diagnoses include galactocele, lactational adenoma, mastitis, abscess, and pregnancy-associated cancer; delays in visualization and drainage worsen outcomes. [8]

Preparation: conditions, consent, positioning

Before the examination, ensure privacy, warm lighting, and the presence of an assistant or companion, if desired. Explain the purpose and sequence of procedures, and ask the patient to remove tight clothing and jewelry. Ask the patient to identify the area of concern while sitting and lying down, so that both glands can be systematically examined. [9]

Starting position: sitting: assess symmetry, contours, skin, and nipples with arms relaxed, then with arms raised and palms resting on thighs (to detect hidden retraction). After inspection, lie down with a cushion placed under the scapula of the side being examined and the arm abducted behind the head, which distributes the tissue and facilitates deep palpation. [10]

For accurate palpation, use the pads of your three middle fingers, moving according to a systematic pattern, varying pressure through three levels: superficial, medium, and deep. This increases reproducibility and the likelihood of detecting lesions at different tissue depths. [11]

The examination takes at least 3 minutes per gland; the best coverage strategy has been shown to be "vertical stripes" from the clavicle to the submammary fold, gradually moving medially and laterally. The areola and nipple are sequentially assessed for lumps and discharge. [12]

Step-by-step palpation technique

Step 1. Systemic scanning of the gland in the supine position using the "vertical stripe" method, avoiding the Spence tail in the axillary direction. Small circular movements are used, monitoring the superficial, mid-level, and deep levels. Any area of tenderness is re-examined at different pressure levels. [13]

Step 2. Nipple and areola assessment: gentle compression to check for spontaneous discharge without causing trauma. Bloody, unilateral, and spontaneous discharge increase the likelihood of intraductal pathology and require imaging and cytology/biopsy. [14]

Step 3. Palpation of the axillary, supra- and subclavian lymph nodes. The patient is seated, the arm is relaxed and slightly abducted; palpation is performed with the fingertips along the anterior, central, posterior and lateral groups with a deepening towards the apex of the armpit; then - the supra- and subclavian fossae. [15]

Step 4. Document the location of the finding: Use a "clock chart" (e.g., "lesion at 2 o'clock, 3 cm from nipple, medium depth"), 3-dimensional dimensions, consistency, mobility relative to the skin and chest wall, tenderness, skin and nipple changes. This documentation facilitates comparison during re-examination and navigation during imaging and biopsy. [16]

How to interpret palpation findings

Signs that increase the likelihood of a benign process include a smooth surface, clear contours, elastic and flexible consistency, cyclical pain, and a decrease after menstruation. Typical examples include a cyst and fibroadenoma, but definitive differentiation is impossible by palpation without visualization. [17]

Suspicious signs include: a dense, "rocky" consistency, uneven contours, attachment to the skin or chest wall, skin or nipple retraction, "lemon peel" appearance, and unilateral bloody discharge. Any such finding requires visualization using age-related algorithms and morphological verification for VI-RADS categories 4-5. [18]

Lymph nodes with alarming signs - hard, enlarged, without fatty "chilium", with thickened cortex, with spider-like fixation - require ultrasound verification and, if suspected, a puncture or core biopsy. [19]

In men, gynecomastia is usually defined as a soft-to-firm, painful disc under the areola; in case of a hard periareolar nodule with skin changes, the tactics are the same as in women: visualization and biopsy as indicated. [20]

Diagnostic value and limitations

As a standalone method for detecting cancer in asymptomatic women, palpation is inferior to imaging in sensitivity. Systematic reviews show that the specificity of clinical examination is comparable to mammography (93-97%), but sensitivity is lower (approximately 40-69%), and its range is highly dependent on training and methodology. [21]

In cases of "palpable mass" symptoms, clinical examination remains important, but the decision on treatment relies on a combination of examination, imaging, and biopsy. In the "real world," it is precisely these combined approaches that increase overall sensitivity and reduce missed diagnoses. [22]

Evidence from the late 1990s onward demonstrated that proper technique improves the yield of clinical examinations: vertical stripes, 3 pressure levels, and a duration of at least 3 minutes per gland are recommended. Even so, this method does not replace screening mammography. [23]

"Triple assessment" remains the gold standard for nodules: agreement between suspicious clinical features, imaging, and cytology/biopsy almost completely confirms the diagnosis; in case of discrepancies, priority is given to morphological verification. [24]

Special situations: pregnancy, lactation, implants

During lactation, any nodes are carefully assessed, as it's easy to miss pathology due to physiological engorgement. Galactoceles and lactational adenomas often mimic tumors; mastitis and abscesses require early visualization and, if necessary, drainage. Rough massage and excessive stimulation increase the risk of injury and worsening inflammation. [25]

The approach to mastitis has been revised in the Clinical Protocol of the Academy of Breastfeeding No. 36 (2022): the main emphasis is on the clinical picture and ultrasound, limiting “aggressive” manipulations, and rational antibacterial therapy for signs of bacterial infection. [26]

With breast implants, palpation is limited due to the masking effect, so symptom assessment is necessarily supplemented by visualization. For silicone implants, if a complication is suspected, magnetic resonance imaging without contrast is the most informative; for asymptomatic implants, magnetic resonance imaging or ultrasound is recommended according to integrity monitoring protocols. [27]

During pregnancy and the early postpartum period, imaging algorithms are adapted with priority given to ultrasound examination; magnetic resonance imaging is discussed individually, taking into account lactation and diagnostic tasks. [28]

Documentation and patient information

The record should include the complaints, triggers and duration, location by clock and distance from the nipple, dimensions in three axes, depth, consistency, mobility, tenderness, skin and nipple changes, lymph node status, preliminary assessment, and imaging plan. A clear map facilitates follow-up and communication with the radiologist and surgeon. [29]

The patient should be explained that palpation is not a screening test or the final word. If warning signs are present, the next steps will be imaging according to an age-specific algorithm and, if necessary, a biopsy. It is important to agree on the timing of follow-up visits and the "alarm signals." [30]

Self-monitoring recommendations: know your "normal," don't ignore new changes, and don't delay a visit if you notice a lump, skin or nipple indentation, unilateral discharge, or persistent inflammation. This is what "breast awareness" means, rather than a formalized self-examination based on a calendar. [31]

For routing, focus on urgent criteria: in women ≥30 years - unexplained lump; in women ≥50 years - nipple and skin changes; persistent lump - for expedited imaging and consultation. [32]

Common mistakes and how to avoid them

Coverage error: missing the "Spence tail" and deep regions when examining with only superficial pressure. Solution: systemic "vertical stripe" pattern, 3 pressure levels, at least 3 minutes per gland. [33]

Positioning error: the lack of a bolster under the scapula and incomplete arm abduction impair access to the lateral compartments. Solution: a bolster, arm behind the head, and methodical advancement from the clavicle to the submammary fold. [34]

Misinterpretation of discharge and "painful lumps": attempts to "squeeze" the contents and aggressive massage. The solution is gentle technique; in case of suspicious discharge, refer for imaging and cytology/biopsy; during lactation, follow modern mastitis management protocols. [35]

Routing error: observation instead of referral for red flags. Solution: use urgent referral criteria and age-based visualization algorithms. [36]

Tables

Table 1. What does clinical palpation show and how does it differ from visualization?

Method	Role	Sensitivity	Specificity	Pros	Restrictions
Palpation	Diagnostic based on symptoms	~40-69%	~93-97%	Available, radiation-free, right from the doctor	Low sensitivity in screening, operator dependence
Mammography	Screening and diagnostics	77-95%	84-92%	Reducing mortality with screening	Lower sensitivity with dense tissue
Ultrasound examination	Diagnostics, especially in dense tissue and in young people	75-90%	80-90%	Radiation-free, biopsy navigation	Dependency operator
Magnetic resonance imaging	Highly sensitive diagnostics in high-risk and complex cases	90-100%	80-98%	High sensitivity	Cost, false positive results

Note: Ranges are indicative based on reviews and comparative studies; tactics are always individual. [37]

Table 2. Algorithm for a palpable formation

Age	First line	If suspected	Verification
<30 years	Ultrasound examination	If there are suspicious signs, add diagnostic mammography	Puncture aspiration biopsy or core biopsy
30-39 years old	Ultrasound examination ± diagnostic mammography	For VI-RADS category 4-5 - biopsy	Guided core biopsy
≥40 years	Diagnostic mammography + ultrasound examination	Referral for biopsy for VI-RADS 4-5	Morphological verification

Based on the American College of Radiology's "Appropriateness Criteria" for Palpable Masses.[38]

Table 3. Red flags and routing according to NICE NG12

Sign	Age	Action
Unexplained palpable formation	≥30	Urgent referral for assessment
Changes in the nipple and skin (retraction, eczema)	≥50	Urgent direction
Unilateral spontaneous discharge	Any	Accelerated visualization and consultation
Supra-/subclavian node	Any	Urgent evaluation of nodes and breasts

Criteria from the Breast Cancer section of the Recognition and Routing Guide. [39]

Table 4. Palpation findings: benign versus suspicious

Sign	Most likely benign	Warning signs of malignancy
Contours	Smooth, clear	Uneven, "crab-shaped"
Consistency	Elastic	Hard, rocky
Mobility	Shifts well	Fixed to the skin or chest wall
Pain	Often there is, cyclical	Most often no, but pain does not rule out cancer.
Skin and nipple	Without retraction	Indrawing, "lemon peel" appearance, bloody discharge

Use the table as a guide, not as a replacement for visualization.[40]

Table 5. Lymph nodes during breast examination

Zone	Where to palpate	What's alarming	The next step
Axillary levels I-III	In relation to the pectoralis minor muscle	Hardness, absence of fatty chyle, thickening of the bark	Ultrasound examination of the node, biopsy
Supra-/subclavian	The pits above and below the collarbone	Increase, density	Ultrasound examination, biopsy
Intrathoracic (internal thoracic)	Non-palpable	-	Guided by visualization

Classification of levels and features according to open reviews and article chapters. [41]

Table 6. Clinical examination documentation

Field	Example of design
Complaint	"Lump on the left for 2 weeks, no pain"
Localization	"2 hours, 3 cm from the nipple"
Size	18×12×10 mm
Consistency and mobility	"Dense, moderately mobile"
Skin and nipple	"No retraction, no discharge"
Lymph nodes	"The axillaries are not enlarged and are painless."
Plan	"Diagnostic mammography + ultrasound examination, with VI-RADS 4-5 - core biopsy"

A unified "hourly" scheme and a fixed set of fields are recommended. [42]

Table 7. Features during pregnancy/lactation and with implants

Situation	Key Features	Tactics
Pregnancy, early postpartum period	Physiological changes mask pathology	In case of nodes - ultrasound examination initially, if indicated - drainage/biopsy
Lactation, mastitis/abscess	Limit trauma and aggressive massage	Modern management protocol, ultrasound examination in case of doubt
Silicone implants	Palpation is limited	If a complication is suspected, magnetic resonance imaging without contrast; integrity control according to regulations

Current review sources and criteria of relevance. [43]

Table 8. Teaching the patient “breast awareness”

What to track	What to do
New nodes, skin/nipple retraction, "lemon peel" appearance	Seek medical attention immediately
Unilateral spontaneous discharge	Urgent assessment
Persistent local pain/swelling	Consultation and visualization
Normal "wave-like" sensitivity	Observe but report persistent changes

Scheduled self-examination has not been shown to be beneficial in reducing mortality; the key is timely response to changes. [44]

Brief navigation through visualization and verification

In the case of a palpable lesion, the first-line treatment depends on the age and clinical presentation: in young women, an ultrasound examination; in women over 40, a diagnostic mammogram with ultrasound examination. Suspicious categories on the imaging scale require morphological verification under control. [45]

If imaging is negative and clinical suspicion persists, a re-examination is necessary: repeat clinical examination, targeted imaging of the problem area, and possibly short-term dynamics. Clinical evaluation is important, but the decision is determined by the sum of the data. [46]

Given updated screening recommendations, starting mammography at age 40 every 2 years remains a strategy with modest benefit for mortality reduction; adjunctive methods for dense tissue are assessed on an individual basis. [47]

Results

1. Palpation is a mandatory part of the in-person diagnostic workup for complaints, but is not a screening tool. 2) In case of "red flags," accelerated visualization and routing are required. 3) The best results of palpation are achieved with a systematic technique, sufficient time, and standard documentation. 4) Tactics are always based on a "triple assessment": clinical presentation, visualization, and morphology. [48]